Fact CheckerSign in

NCT03902431Completed

Translating the ABCS Into HIV Care

Implementation Research: Translating the ABCS Into HIV Care

Source: ClinicalTrials.gov · Last updated 19 Sept 2024

Brief summary (registry, in English)

The overall objective of this project is to develop and rigorously test implementation strategies to address the gap in scientific knowledge of lower use of evidence-based interventions commonly referred to as the ABCS (aspirin, blood pressure control, cholesterol control, and smoking cessation)which contributes to the growing CVD morbidity and mortality among PLH.

Status (registry)
Completed
Study type
Interventional
Enrollment
4277 (actual)
First submitted
1 Apr 2019
Start date
26 Sept 2019
Primary completion date
31 Aug 2022
Lead sponsor
University of Rochester
Diseases
HIV
NCT number
NCT03902431

What you commit to

  • Study type: Interventional
  • Participants enrolled: 4277
  • From 26 Sept 2019 to the primary completion date, 31 Aug 2022
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Have experienced a prior cardiac or vascular event such as myocardial infarction (MI) or cerebrovascular accident (CVA)

Other illness

  • Have peripheral vascular disease, intermittent claudication or peripheral arterial disease

Other

  • Patients:
  • Currently participating in another CVD trial
  • Have had a CVD procedure such as installation of a stent or angioplasty
  • Are pregnant
  • Lacks capacity to consent
    • Clinicians:
  • Planning to leave the site within the next 12 months

Who the study is looking for

  • Sites:
  • Serve a cohort of at least 100 HIV patients
  • Have an Electronic Health Record (EHR)
  • Agree to collaborate on implementing feasible adaptations of intervention strategies
    • Patients:
  • Patient of the site with a diagnosis of HIV
  • Age 40-79 years
  • ≥5% risk for CVD as calculated using the ASCVD Risk Estimator Plus
  • Willing to participate
  • No plans to leave the site in the next 12 months
  • Proficient in either English or Spanish
  • Own a cell phone with texting capabilities
    • Clinicians:
  • Physicians, Physicians Assistants, or Nurse Practitioners who provide direct HIV care to patients
  • Work at a participating site
  • Willing to implement the project's intervention strategies

Age in the registry: 40 years to 79 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Rochester
Coordinator of this site? Confirm its status
RochesterUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.